Rocket Pharmaceuticals, Inc. is a clinical-stage gene therapy company developing treatments for rare, devastating diseases. Its pipeline includes lentiviral vector (LV) and adeno-associated virus (AAV) based therapies targeting conditions such as Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), Pyruvate Kinase Deficiency (PKD), Danon Disease (DD), PKP2-Arrhythmogenic Cardiomyopathy (PKP2-ACM), BAG3-Dilated Cardiomyopathy (BAG3-DCM), and other rare genetic and cardiac disorders.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076551 | EDGAR | 79K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-029002 | EDGAR | 87K words |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021096 | EDGAR | 90K words |
| 2023-02-28 | 2022-12-31 | 0001140361-23-009252 | EDGAR | 95K words |
| 2022-02-28 | 2021-12-31 | 0001140361-22-007036 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001140361-21-006677 | EDGAR | — |
| 2020-03-06 | 2019-12-31 | 0001140361-20-005056 | EDGAR | — |
| 2019-03-08 | 2018-12-31 | 0001140361-19-004603 | EDGAR | — |
| 2018-03-07 | 2017-12-31 | 0001564590-18-004621 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004532 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001193125-26-342348 | EDGAR | 30K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269474 | EDGAR | 29K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104996 | EDGAR | 28K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066898 | EDGAR | 25K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123459 | EDGAR | 28K words |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091838 | EDGAR | 27K words |
| 2024-05-07 | 2024-03-31 | 0000950170-24-054465 | EDGAR | 26K words |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060339 | EDGAR | 31K words |
| 2023-08-09 | 2023-06-30 | 0001140361-23-038855 | EDGAR | 30K words |
| 2023-05-05 | 2023-03-31 | 0001140361-23-023233 | EDGAR | 28K words |
| 2022-11-04 | 2022-09-30 | 0001140361-22-040004 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001140361-22-028904 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-15 | 0001140361-26-036563 | EDGAR | 1K words |
| 2026-08-27 | 0001140361-26-034689 | EDGAR | 2K words |
| 2026-08-10 | 0001140361-26-032028 | EDGAR | 4K words |
| 2026-08-03 | 0001140361-26-030568 | EDGAR | 1K words |
| 2026-03-27 | 0001140361-26-011573 | EDGAR | 2K words |
| 2026-03-10 | 0001140361-26-008853 | EDGAR | 27K words |
| 2026-02-26 | 0001140361-26-006981 | EDGAR | 2K words |
| 2025-11-06 | 0001140361-25-040774 | EDGAR | 3K words |
| 2025-10-14 | 0001140361-25-038030 | EDGAR | 1K words |
| 2025-10-03 | 0001140361-25-037237 | EDGAR | 0K words |
239 total filings indexed. 207 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001281895 |
| Ticker | RCKT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.rocketpharma.com |
| Listed | 2015-02-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RCKT (~200 tokens, structured JSON with cryptographic provenance)